In a report released yesterday, Jasper Hellweg from Argus Research maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report).

Shares of Baxter International Inc. BAX advanced 2.74% to $30.41 Thursday, on what proved to be an all-around great trading ...

Meet the ‘race fakers’ — and the people tracking them down - When Rachel Dolezal was revealed to be white in 2015, it seemed ...

Theradaptive, a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, is pleased to announce the appointment of Daniel Wolf as Chief Financial Officer ...

There was not an empty seat in the George Houston Gymnasium on Saturday night except for when performances finished and fans rose to their feet in applause to celebrate the Juneau-Douglas High School: ...

The stock's fall snapped a two-day winning streak.

President Donald Trump's administration has escalated its ongoing battle with Harvard, threatening to revoke the university’s ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent ...

In trading on Friday, shares of Baxter International Inc (Symbol: BAX) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $26.80 per share. By ...

Hemopatch Sealing Hemostat with room temperature storage now available in Europe New product evolution enables direct accessibility in the operating room Innovation is a direct result of collaborative ...